If the idea of weekly injections has always put you off, you are far from alone. Many people want proper clinical support with their weight but would simply prefer to take a tablet. That is exactly why orforglipron has attracted so much attention this year.
Orforglipron is a once daily GLP 1 tablet that can help you feel full sooner and reduce your appetite, making it easier to eat less. Here, we look at how it works, what the evidence shows and who it may suit.
What Is Orforglipron?
Orforglipron is a prescription only weight loss tablet, sold under the brand name Foundayo and developed by Eli Lilly. The MHRA authorised it in August 2026, making the UK the first country in Europe to approve it for weight management and type 2 diabetes.
It belongs to the same wider family of medicines as Mounjaro and Wegovy. If you are weighing up your options, our guide on how Mounjaro compares with other weight loss injections is a helpful starting point.
How Does the Orforglipron Pill Work?
Orforglipron works by copying GLP 1, a natural hormone your gut releases after eating that helps signal to your brain that you have had enough. It can support weight loss in three main ways:
- Reduced appetite: it acts on the areas of the brain that control hunger, so cravings and constant thoughts about food may ease
- Slower digestion: food leaves the stomach more gradually, helping fullness last longer
- Blood sugar support: it helps the body release insulin after meals
These effects can help reduce calorie intake over time. Orforglipron is therefore licensed for use alongside a reduced calorie diet and more physical activity, rather than as a standalone fix.
Why Can Orforglipron Be Taken as a Tablet?
Orforglipron can be taken as a tablet because it is a small molecule rather than a peptide. Most GLP 1 medicines are peptides, which the digestive system breaks down before they can be absorbed. Orforglipron can survive digestion, allowing it to be taken at any time of day, with or without food. For people who dislike needles, it offers an alternative to weekly treatments such as Wegovy injections.
How Effective Is Orforglipron for Weight Loss?
In clinical trials, people on the highest dose who stayed on treatment lost an average of 12.4% of their body weight over 72 weeks. Across all participants, including those who stopped early, average weight loss was 11.1%, compared with 2.1% on placebo.
Results vary from person to person. Some injectable treatments have produced higher trial results, so the most suitable option will depend on your health, preferences and how your body responds.
Who Can Take Orforglipron in the UK?
Orforglipron is licensed for adults with a BMI of 30 or above, or a BMI between 27 and 30 with at least one health condition linked to weight, such as high blood pressure. It is not currently available on the NHS, as NICE has yet to complete its assessment, so access is through a private prescription following a clinical consultation.
It may not be suitable if you are pregnant, already taking another GLP-1 medicine, or have a personal or family history of certain thyroid cancers. The NHS guidance on treating obesity explains how medicines fit alongside diet and exercise.
What Side Effects Can Orforglipron Cause?
The most common side effects are digestive, including nausea, constipation, diarrhoea, vomiting, indigestion and stomach pain. These symptoms are often more noticeable when treatment starts or the dose increases, which is why the dose is introduced gradually. Seek medical advice promptly if you experience severe, persistent stomach pain or notice a lump or swelling in your neck.
Start Your Weight Loss Journey with Touchwood Pharmacy
A new tablet is exciting news, but the right treatment is the one that fits your health, lifestyle and goals. At Touchwood Pharmacy, we offer private weight loss consultations with a GPhC-registered prescriber, so you understand every suitable option before you begin.
Rather than trying to work it out alone, book your weight loss consultation with Touchwood Pharmacy today.
Frequently Asked Questions
Is orforglipron available in the UK?
Yes. It was authorised by the MHRA in August 2026 as a prescription only medicine. It is currently available privately rather than on the NHS.
How often do you take the orforglipron pill?
It is taken once a day, at any time, with or without food.
Is orforglipron the same as Mounjaro?
No. Both are made by Eli Lilly, but Mounjaro is a weekly injection that acts on two hormone pathways, while orforglipron is a daily tablet that acts on GLP-1 only.
How quickly does orforglipron work?
Some people notice changes in appetite within the first few weeks. Weight loss is gradual, and trial results were measured over 72 weeks.
Can I switch from injections to orforglipron?
Possibly, but switching should always be assessed by a prescriber, who will consider your current dose, progress and medical history.
What happens if I stop taking orforglipron?
As with other GLP 1 medicines, your appetite may return and some weight regain is possible. Maintaining healthy eating and activity habits can continue to support your weight management.
